Brennan, Manna & Diamond
Listen. Solve. Empower.
Diversity & Inclusion
Client Alerts, News Articles, Blog Posts, & Multimedia
Everything you need to know about BMD and the industry.
Five Things That Owners and Boards Need to Know About Privacy and Cybersecurity Compliance
August 21, 2020
Five tips for owners and boards about privacy and cybersecurity compliance.
DOJ Updates Corporate Compliance Plan Guidance
June 18, 2020
With the passage of the Affordable Care Act in 2010, all healthcare providers were required to adopt and implement a corporate compliance plan. Historically, having an effective corporate compliance plan in place has been key to defending healthcare providers in fraud and abuse actions by Medicare, Medicaid, and commercial payers. Over the past couple of years, the U.S. Department of Justice’s (DOJ) Criminal Division has increased the number of prosecutions against U.S. corporations, including healthcare providers. Earlier this month, the DOJ’s Criminal Division updated its “Evaluation of Corporate Compliance Programs” guidance to educate prosecutors on how a corporate compliance program will be evaluated going forward.
Jeana Singleton & Richard Crosby
Urine Drug Testing Best Practices
August 18, 2016
The purpose of this suggested compliance plan is to provide guidance and best practices for prescribers of opiates and benzodiazepines. Compliance with OARRS is required. In addition, urine drug testing (UDT) among pain management physicians, OBGYNs, psychiatrists, and orthopedics is a useful tool that can not only assist in diagnostic and therapeutic decision making, but can also be used as a personal risk reduction tool for those physicians prescribing pain medications.
Brennan Manna Diamond